10.12.2012 Views

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>School</strong> <strong>of</strong> <strong>Nursing</strong> & <strong>Midwifery</strong>, <strong>Trinity</strong> College Dublin: 8 th Annual Interdisciplinary Research <strong>Conference</strong><br />

Transforming Healthcare Through Research, Education & Technology: 7 th – 9 th November 2007<br />

<strong>Conference</strong> <strong>Proceedings</strong><br />

weeks, data were collected for a total <strong>of</strong> five cycles or for fifteen<br />

weeks from patients in both groups.<br />

Inclusion Criteria<br />

All patients included in this study were older than sixteen years <strong>of</strong><br />

age. They had a diagnosis <strong>of</strong> either breast or colorectal cancer<br />

requiring adjuvant chemotherapy. The reasons for choosing this<br />

group <strong>of</strong> patients was that their cancer had hopefully been removed<br />

at the time <strong>of</strong> their surgery and therefore the chemotherapy was<br />

being given to prevent further recurrence <strong>of</strong> their disease. Their<br />

overall long term survival was likely to be similar. They all either<br />

required six courses <strong>of</strong> chemotherapy at three weekly intervals or<br />

continuous chemotherapy over a twenty-four week period. They all<br />

had normal blood full blood counts and urea and electrolytes and<br />

were able to give written informed consent.<br />

Exclusion Criteria<br />

No pregnant participants were included. Patients with cerebral<br />

metastasis were excluded, as they would be receiving palliative<br />

rather than adjuvant chemotherapy. The visually impaired were<br />

excluded as the study involved completing several forms which may<br />

have proved difficult for them. Patients receiving radiotherapy to<br />

the abdominal or pelvic region were excluded as it would indicate<br />

advanced disease and may also have caused severe abdominal<br />

disturbance resulting in the patient complaining <strong>of</strong> vomiting or<br />

diarrhoea not related to chemotherapy. Patients unable to give<br />

informed consent were excluded as it would have been unethical to<br />

recruit them to the study.<br />

Any patients that the health care team identified as extremely<br />

anxious or as having a known psychiatric illness were also excluded<br />

as these patients may have skewed the study. Different<br />

arrangements are made for this group <strong>of</strong> patients within the<br />

department which rendered them ineligible for this study. Patients<br />

receiving palliative chemotherapy were excluded as their disease<br />

progression could actually contribute to an increase in patterns <strong>of</strong><br />

nausea and vomiting which again would have skewed the results.<br />

Outcome Measures<br />

Having considered many <strong>of</strong> the tools that were rigorously tested and<br />

found to be reliable in quality <strong>of</strong> life cancer studies, the RSCL and<br />

the HADS were chosen for this study. These two tools represent the<br />

most practical and reliable measures for assessing quality <strong>of</strong> life<br />

issues for cancer patients (Slevin 1992). In a study conducted by<br />

Hope-Stone et al (1997) these tools were used together to measure<br />

quality <strong>of</strong> life issues in advanced colorectal cancer research patients<br />

and were found to be easy to complete by most patients.<br />

- 189 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!